Granules India Ltd - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd Granules India Ltd - 532482 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Prasad Chigurupati Granules India's arm gets USFDA approval for Amphetamine Sulfate tablets
Drug firm Granules India on Tuesday said its US arm has received approval from the USFDA for a generic central nervous system stimulant drug- Ampheta Granules India Ltd - 532482 - Granules Pharmaceuticals, Inc. Received US FDA Approval For Amphetamine Sulfate Tablets.
Granules Pharmaceuticals, Inc. Received US FDA Approval for Amphetamine Sulfate Tablets. GRANULES INDIA LTD.-$ - 532482 - Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation of Book Closure Pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 GRANULES INDIA LTD.-$ - 532482 - Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities & Exchnage Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Intimation of Book Closure pursuant to Regulation 42 of the Securities & Exchnage Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. GRANULES INDIA LTD.-$ - 532482 - Reg. 34 (1) Annual Report
Regulation 34(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Submission of Annual Report for the FY 2018-19. Granules India Ltd - 532482 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 011110 Name of the Signatory :- chaitanya tummalaDesignation :- Company Secretary and Compliance Officer Granules India Ltd - 532482 - Intimation Of Record Date Pursuant To Regulation 42 Of Securities & Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015
Intimation of Record Date Pursuant to Regulation 42 of Securities & Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015